Apoptosis is mediated by cytosolic phospholipase A2 during simulated ischaemia/reperfusion-induced injury in neonatal cardiac myocytes

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 77, Issue 1, 2007, Pages 37-43

  Engelbrecht, A M ^a   Ellis, B ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONYLTRIFLUOROMETHYL KETONE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOSOL; ENZYME ACTIVATION; GROUP IV PHOSPHOLIPASES A2; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 34547830416     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.06.002     Document Type: Article

References (26)

1. Gill C., Mestril R., and Samali A. Losing heart; the role of apoptosis in heart disease-a novel therapeutic target?. FASEB J. 16 (2002) 135-146
2. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N. Engl. J. Med. 336 (1997) 1131-1141
3. Narula J., Haider N., Virmani R., et al. Programmed myocyte death in end-stage heart failure. N. Eng. J. Med. 335 (1996) 1182-1189
4. Saraste A., Pulkki K., Kallajoki M., Hendriksen K., Parvinen M., and Viopoi-Pulkki L.-M. Apoptosis in human acute myocardial infarction. Circulation 95 (1997) 320-323
5. Kajstura J.W., Cheng W., Reiss K., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 79 (1996) 949-956
6. 2. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 175-189
7. 2. Trends Pharmacol. Sci. 20 (1999) 162-170
8. 2+)-dependent translocation domain with homology to PKC and GAP. Cell 65 (1991) 1043-1051
9. Song C., Chang X.J., Bean K.M., Proia M.S., Knopf J.L., and Kriz R.W. Molecular characterization of cytosolic phospholipase A2-beta. J. Biol. Chem. 274 (1999) 17063-17067
10. Tang J., Kriz R.W., Wolfman N., Shaffer M., Seehra J., and Jones S.S. A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J. Biol. Chem. 272 (1997) 8567-8575
11. Underwood K.W., Song C., Kriz R.W., Chang X.J., Knopf J.L., and Lin L.L. A novel calcium-independent phospholipase A2, cPLA2-gamma that is prenylated and contains homology to cPLA2. J. Biol. Chem. 273 (1998) 21926-21932
12. Huang Z., Payette P., Abdullah K., Cromlish W.A., and Kennedy B.P. Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2. Biochemistry 26 (1996) 3712-3721
13. Gijon M.A., and Leslie C.C. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukocyte Biol. 65 (1999) 330-336
14. Pinson A., Tirosh R., Tremblover V., and Shohami E. Oxygen deprivation and reoxygenation augment prostacyclin synthesis in cultured ventricular myocytes. Prostaglandins Leukotr. Essent. Fatty Acids 54 (1996) 211-215
15. Engelbrecht A.M., Niesler C., Page C., and Lochner A. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res. Cardiol. 99 (2004) 338-350
16. Gomez L.A., Alekseev A.E., Aleksandrova L.A., Brady P.A., and Terzic A. Use of MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. Mol. Cell Cardiol. 29 (1997) 1255-1266
17. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 71 (1976) 248-254
18. Ilic D., Eduardo A.C., Schlaepfer D.D., Dazin P., Aizawa S., and Damsky C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143 (1998) 547-560
19. 2 by 42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268 (1993) 1960-1964
20. 2. J. Biol. Chem. 272 (1997) 16907-16912
21. + current ITREK in cardiomyocytes. J. Biol. Chem. 275 (2000) 39110-39116
22. 2. J. Biol. Chem. 272 (1997) 16712-16907
23. Mackay K., and Mochly-Rosen D. Involvement of p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia. J. Mol. Cell Cardiol. 32 (2000) 1585-1588
24. Abe J.-I., Baines C.P., and Berk B.C. Role of mitogen-activated protein kinases in ischemia and reperfusion injury. Circ. Res. 86 (2000) 607-609
25. Yue T.-L., Wang C., Gu J.-L., et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 86 (2000) 692-699
26. Takai S., Haruhiko T., Yoshida M., et al. Prostaglandin D2 induces the phosphorylation of HSP in osteoblasts: function of the MAP kinase superfamily. Prostaglandins Leukotr. Essent. Fatty Acids 75 (2006) 61-67